Antimicrobial cream plus standard care for complicated leishmaniasis sores
Part of Infections, Skin clinical trials.
This study tests medicines added to standard treatment to improve healing of complicated skin sores (leishmaniasis) by balancing the bacteria on the skin. You may qualify if you have sores that need whole-body treatment and you are willing to stay in the hospital for 4 weeks.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with cutaneous leishmaniasis (skin sores caused by a sandfly bite).
- Your sores need stronger, whole-body treatment because they are large, many, near your nose or mouth, on joints, not healing with creams, or spreading.
- You have at least one open, crusty, or scaly sore that is not inside your nose or on the inner lip and is at least half a centimeter away from other sores.
- You are older than 4 years and can stay in the hospital for 4 weeks (or have a parent/guardian's permission if under 18).
- You have not used any special wound medicines, antibiotics, or leishmaniasis treatments in the last month.
- You are not pregnant or breastfeeding, and your blood tests (kidney, liver, heart) are within safe limits.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether arnica tincture (a plant extract) can treat cutaneous leishmaniasis, an infection causing skin ulcers. It compares arnica to a standard injected treatment and looks at how well each works and how safe they are.
This study tests how your immune system responds to parts of a potential vaccine for leishmaniasis. Doctors will take small blood or skin samples to see if your body's cells react to these vaccine pieces, which could help design a better vaccine in the future.
This study tests different drugs to find which works best for cutaneous leishmaniasis (a skin infection from a parasite). It may help people with many or large sores, or sores in sensitive areas like near the eyes or nose.
This trial compares two approaches for treating skin sores caused by Leishmania: standard injections alone versus injections plus a laser treatment. It aims to see if adding laser therapy improves healing.
This study tests a gel form of miltefosine applied directly to skin sores caused by leishmaniasis. It is for adults with mild to moderate skin infections who have not already tried and failed other treatments.
This study tests if using heat therapy (thermotherapy) in local clinics is a good way to treat skin sores caused by leishmaniasis. It may be an option for people with a few small sores not on the face or near sensitive areas.
Hear when a new Leishmaniasis, Cutaneous trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.